includes:trial - GLP1 Guide

includes:trial

A collection of 15 posts

A high quality GLP1 pill: once-daily Orforglipron

drug:orforglipron

A high quality GLP1 pill: once-daily Orforglipron

We take a look at the most recent set of results from Orforglipron, the oral GLP1 from Eli Lilly

CagriSema underperforms in trial

CagriSema underperforms in trial

We take a look at the recent results for CagriSema, and see how it tracks against other GLP1s

Mounjaro vs Trulicity in a clinical trial

Trulicity and Mounjaro go head to head, in a clinical trial that finally puts to bed the question of which is better.

Boosting GLP1s with Phentermine

drug:phentermine

Boosting GLP1s with Phentermine

Reports of combining GLP1s with Phentermine suggest superior results. What is Phentermine and how can it be used with GLP1s?

drug:orforglipron

Updates from MariTide & Orforglipron research

MariTide and Orfoglipron updates from the ADA 85th Science Sessions conference in June, with the key results that were announced.

Preserving muscle: GLP1s with Bimagrumab

Preserving muscle: GLP1s with Bimagrumab

We deep dive on Bimagrumab, a muscle-preserving booster to GLP1 receptor agonists like Ozempic, Wegovy, Mounjaro, Zepbound and others.

Amylin, with and without GLP1: Eloralinitide

drug:eloralinitide

Amylin, with and without GLP1: Eloralinitide

We dig into early results around Eloralinitide, an amylin-based weight loss formulation being developed by Eli Lilly.

Semaglutide vs Tirzepatide (Clinical trial)

Finally, a research clinical trial that directly explores the difference between Semaglutide and Tirzepatide for Obesity.

GLP1s lower inflammation, Psoriasis, AND increase fertility?

category:benefits

GLP1s lower inflammation, Psoriasis, AND increase fertility?

We look into the anti-inflammatory effects of GLP1s and their effects on issues like psoriasis and infertility.

Semaglutide & Liraglutide continue to be effective

chemical:semaglutide

Semaglutide & Liraglutide continue to be effective

Semaglutide and Liraglutide continue to be researched and studied and produce positive results for weight loss and medical outcomes.

Amgen's GLP1: MariTide (formerly AMG-133)

Amgen's GLP1: MariTide (formerly AMG-133)

Amgen is working on a new GLP1, entering the race -- AM-133. We dig into the trials and research and see if it's got any promise.

Eli Lilly's other new GLP1 - Orforglipron

company:eli-lilly

Eli Lilly's other new GLP1 - Orforglipron

Eli Lilly is developing new GLP1 drugs, and Orforglipron is one of them. It's not easy to pronounce, but it is easy to take, and easy to produce.

Pfizer's GLP1: Danuglipron

drug:danuglipron

Pfizer's GLP1: Danuglipron

Read more about Dangulipron, Pfizer's GLP1 receptor agonist. Will it be better than Ozempic, Wegovy, Mounjaro, Zepbound and others?

Survodutide, a new GLP1 + GCGR agonist

chemical:servodutide

Survodutide, a new GLP1 + GCGR agonist

As the GLP1 Receptor Agonist class of drugs make much progress and receive a lot of attention, pharma companies are lining up to produce more and better kinds of GLP1 drugs. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound

A pill instead of injection - A 2020 study on Rybelsus

A pill instead of injection - A 2020 study on Rybelsus

Rybelsus is a form of Semaglutide that you can take as a pill, rather than injection. If you're not familiar with Semaglutide, it's one of the GLP1 Receptor Agonist class of drugs that are taking the world by storm right now (Ozempic, Wegovy, and Rybelsus are